Mosby's 2014 Nursing Drug Reference (433 page)

BOOK: Mosby's 2014 Nursing Drug Reference
8.08Mb size Format: txt, pdf, ePub
lorcaserin

(lor-ca-ser′in)

Belviq

Func. class.:
Weight-control agent (anorexiant)

Chem. class.:
Serotonin 2C (5-HT
2C
) receptor agonist

ACTION:

Decreases food consumption and decreases hunger by selectively activating 5-HT
2C
receptors

USES:

Obesity management

CONTRAINDICATIONS:

Pregnancy (X), breastfeeding, hypersensitivity, severe renal impairment

Precautions:
Children, other organic causes of obesity, anemia, AV block, bradycardia, bundle branch block, depression, dialysis, liver/kidney disease, multiple myeloma, neutropenia, suicidal ideation, Peyronie’s disease, pulmonary hypertension, sick sinus syndrome

DOSAGE AND ROUTES
Calculator
Adult:

• 
PO
10 mg bid; do not exceed recommended dosage

Available forms:
Tabs, film-coated 10 mg

Administer:

• 
For obesity if patient is on weight reduction program that includes dietary changes, exercise

• 
May give without regard to food

SIDE EFFECTS

CNS:
Insomnia, depression, serotonin syndrome, anxiety,
suicidal ideation,
dizziness, headache, fatigue

CV:
Bradycardia, hypertension

GI:
Diarrhea, constipation, nausea

HEMA:
Neutropenia, leukopenia, lymphopenia

INTEG:
Rash

MS:
Back pain

PHARMACOKINETICS

70% protein binding, half-life 11 hr

INTERACTIONS

Increase:
life-threatening serotonin syndrome or NMS—SSRIs, SNRIs, serotonin-receptor agonists, sibutramine, MAOIs, linezolid, tricyclic antidepressants, buPROPion, lithium, DOPamine antagonist, traMADol

Increase:
risk of hypoglycemia with sulfonylureas and insulin

Drug/Herb

Increase:
Serotonin syndrome—St. John’s wort

NURSING CONSIDERATIONS
Assess:

• 
Weight weekly; oral hypoglycemic dosage might need to be reduced in diabetic patients

• 
Monitor blood glucose, CBC with differential, Hct/Hgb, serum prolactin

 
Pregnancy (X): do not use in pregnancy

Suicidal ideation:

 
Use caution in psychiatric disorders with emotional lability; assess for depression, suicidal thoughts/behaviors

Evaluate:

• 
Therapeutic response: decrease in weight

Teach patient/family:

• 
To avoid hazardous activities until stabilized on medication

• 
To discuss unpleasant side effects

 
To notify prescriber if pregnancy is planned or suspected, pregnancy X

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

lucinactant

(loo′sin-ak′tant)

Surfaxin

Func. class.:
Synthetic lung surfactant

USES:

Prevention of respiratory distress syndrome in premature neonates (RDS)

DOSAGE AND ROUTES
Calculator
Premature neonate

Intratracheal
5.8 ml/kg birth weight divided in 4 doses; give each dose with neonate in a different position; provide positive pressure ventilation when stable; dosage may be repeated 4 times in first 48 hr

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

mirabegron

(mir′a-beg′ron)

Myrbetriq

Func. class.:
Bladder antispasmodic

Chem. class.:
β
3
Adrenergic receptor agonist

ACTION:

Relaxes smooth muscles in urinary tract

USES:

Overactive bladder (urinary frequency, urgency), urinary incontinence

CONTRAINDICATIONS:

Hypersensitivity

Precautions:
Pregnancy (C), breastfeeding, children, kidney/liver disease, bladder obstruction, dialysis, hypertension

DOSAGE AND ROUTES
Calculator

• Adult:
PO
25 mg/day, may increase to 50 mg/day if needed

Hepatic/renal dose

 
PO
Child–Pugh B or (CCr 15-29 ml/min, max 25 mg/day; Child–Pugh C or CCr <15 ml/min, not recommended

Available forms:
Tabs ext rel 25, 50 mg

Administer:

• 
Give whole; take with liquids; do not crush, chew, or break ext rel product; use without regard to meals

SIDE EFFECTS

CNS:
Fatigue, dizziness, headache

CV:
Hypertension

EENT:
Xerophthalmia, blurred vision

GI:
Nausea, vomiting, anorexia, abdominal pain, constipation, diarrhea, dyspepsia

GU:
Dysuria, urinary retention, frequency, UTI, bladder discomfort

INTEG:
Rash, pruritus

MISC:
Arthralgia, back pain

RESP:
Pharyngitis

SYST:
Stevens–Johnson syndrome

PHARMACOKINETICS

71% protein binding, excretion 25% unchanged in urine, terminal half-life 50 hr, peak 3.5 hr

INTERACTIONS

Increase:
Effect of digoxin, warfarin, desipramine, thioridazine, flecainide, propafenone

Increase:
risk of urinary retention with antimuscarinic agents (eg, atropine, scopolamine)

NURSING CONSIDERATIONS
Assess:

• 
Urinary patterns: distention, nocturia, frequency, urgency, incontinence

• 
LFTs at baseline, periodically

• 
Monitor B/P

Evaluate:

• 
Decreasing dysuria, frequency, nocturia, incontinence

Teach patient/family:

• 
To avoid hazardous activities; dizziness can occur

• 
Not to drink liquids before bedtime

• 
About the importance of bladder maintenance

Other books

I Will Rise by Michael Louis Calvillo
Made to Love by Syd Parker
1636: The Cardinal Virtues by Eric Flint, Walter H Hunt
Treasure Hunt by Andrea Camilleri
Girl in a Band by Kim Gordon